Bringing a new product to market is a risky, not to mention daunting, venture. Doing so in a new country with a complex healthcare system and different regulatory environment can be even more challenging.
Since MATTER’s founding in 2015, we’ve partnered with the Consulate General of Canada each year to advise Canadian life science and healthcare entrepreneurs. Called the Canada-Chicago Mentoring Program (C2MP), MATTER mentors help Canadian entrepreneurs refine their business development strategy for the U.S. healthcare market, increasing their chances of success upon launch.
The following startups have participated in C2MP:
2025:
Canurta Therapeutics
Deep Breathe
MindfulGarden
Myomar Molecular
Possibility Neurotechnologies
2024:
PragmaClin
FemTherapeutics
Neuraura
Strata Health
2023:
Careteam Technologies
Cerebra
Fluid Biomed
HealthEMe
Mikata Health
2022:
CANImmunize
Hyivy
Sensoreal
ViewsIQ
2021:
Able Innovations
KA Imaging
Luxsonic
Oncoustics
2020:
Axem Neurotechnology
Cohesys
Motryx
OPTT
Torus Biomedical Solutions
True Angle
2019:
Health Gauge
OptiSolve
RUNWITHIT Synthetics
Tieös Pharmaceuticals
Umay
2018:
NXTSENS
Mediphage
Elsius
Steadiwear
Ovensa
2017:
Prolucid
Densitas
CDRD (now adMare BioInnovations)
2016:
Three Rivers Cardiovascular
Bresotec
Mannin Research
2015:
Innovere Medical
Rna Diagnostics
NerveVision
